BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33501708)

  • 21. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
    Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
    JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial.
    Eisen A; Bonaca MP; Jarolim P; Scirica BM; White HD; Tendera M; Dellborg M; Nicolau JC; Morais J; Fox KA; Bohula EA; Murphy SA; Braunwald E; Morrow DA
    Clin Chem; 2017 Jan; 63(1):307-315. PubMed ID: 28062625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
    Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
    JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
    Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
    Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction.
    Salbach C; Mueller-Hennessen M; Biener M; Stoyanov K; Preusch M; Kihm L; Merle U; Schnitzler P; Katus HA; Giannitsis E
    Biomarkers; 2021 Jul; 26(5):401-409. PubMed ID: 33998352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin.
    Maino A; Di Stasio E; Grimaldi MC; Cappannoli L; Rocco E; Vergallo R; Biscetti F; Baroni S; Urbani A; Landolfi R; Biasucci LM
    Int J Cardiol; 2021 Sep; 338():278-285. PubMed ID: 34157355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?
    Anders B; Alonso A; Artemis D; Schäfer A; Ebert A; Kablau M; Fluechter S; Findeisen P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 36(3):211-7. PubMed ID: 24135532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates.
    Grave C; Gabet A; Puymirat E; Empana JP; Tuppin P; Danchin N; Olié V
    Arch Cardiovasc Dis; 2021 Dec; 114(12):768-780. PubMed ID: 34840126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.
    Fardman A; Zahger D; Orvin K; Oren D; Kofman N; Mohsen J; Tsafrir O; Asher E; Rubinshtein R; Jamal J; Efraim R; Halabi M; Shacham Y; Fortis LH; Cohen T; Klempfner R; Segev A; Beigel R; Matetzky S
    PLoS One; 2021; 16(6):e0253524. PubMed ID: 34143840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between cardiac injury and outcomes in hospitalized patients with COVID-19.
    Karbalai Saleh S; Oraii A; Soleimani A; Hadadi A; Shajari Z; Montazeri M; Moradi H; Talebpour M; Sadat Naseri A; Balali P; Akhbari M; Ashraf H
    Intern Emerg Med; 2020 Nov; 15(8):1415-1424. PubMed ID: 32772283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
    He XW; Lai JS; Cheng J; Wang MW; Liu YJ; Xiao ZC; Xu C; Li SS; Zeng HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):456-460. PubMed ID: 32171190
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
    Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
    Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
    [No Abstract]   [Full Text] [Related]  

  • 34. The prognostic significance of troponin I elevation in acute ischemic stroke.
    Batal O; Jentzer J; Balaney B; Kolia N; Hickey G; Dardari Z; Reddy V; Jovin T; Hammer M; Gorcsan J; Schmidhofer M
    J Crit Care; 2016 Feb; 31(1):41-7. PubMed ID: 26547807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19.
    Melillo F; Napolano A; Loffi M; Regazzoni V; Boccellino A; Danzi GB; Cappelletti AM; Rovere-Querini P; Landoni G; Ingallina G; Stella S; Ancona F; Dagna L; Scarpellini P; Ripa M; Castagna A; Tresoldi M; Zangrillo A; Ciceri F; Agricola E
    Eur J Clin Invest; 2022 Jan; 52(1):e13703. PubMed ID: 34706062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.
    Rodríguez-Leor O; Cid-Álvarez B; Pérez de Prado A; Rossello X; Ojeda S; Serrador A; López-Palop R; Martín-Moreiras J; Rumoroso JR; Cequier Á; Ibáñez B; Cruz-González I; Romaguera R; Moreno R; ; Villa M; Ruíz-Salmerón R; Molano F; Sánchez C; Muñoz-García E; Íñigo L; Herrador J; Gómez-Menchero A; Gómez-Menchero A; Caballero J; Ojeda S; Cárdenas M; Gheorghe L; Oneto J; Morales F; Valencia F; Ruíz JR; Diarte JA; Avanzas P; Rondán J; Peral V; Pernasetti LV; Hernández J; Bosa F; Lorenzo PLM; Jiménez F; Hernández JMT; Jiménez-Mazuecos J; Lozano F; Moreu J; Novo E; Robles J; Moreiras JM; Fernández-Vázquez F; Amat-Santos IJ; Gómez-Hospital JA; García-Picart J; Blanco BGD; Regueiro A; Carrillo-Suárez X; Tizón H; Mohandes M; Casanova J; Agudelo-Montañez V; Muñoz JF; Franco J; Del Castillo R; Salinas P; Elizaga J; Sarnago F; Jiménez-Valero S; Rivero F; Oteo JF; Alegría-Barrero E; Sánchez-Recalde Á; Ruíz V; Pinar E; Pinar E; Planas A; Ledesma BL; Berenguer A; Fernández-Cisnal A; Aguar P; Pomar F; Jerez M; Torres F; García R; Frutos A; Nodar JMR; García K; Sáez R; Torres A; Tellería M; Sadaba M; Mínguez JRL; Merchán JCR; Portales J; Trillo R; Aldama G; Fernández S; Santás M; Pérez MPP
    Rev Esp Cardiol (Engl Ed); 2020 Dec; 73(12):994-1002. PubMed ID: 32917566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection.
    Caro-Codón J; Rey JR; Buño A; Iniesta AM; Rosillo SO; Castrejon-Castrejon S; Merino C; Marco I; Martinez LA; Garcia-Veas JM; Martin-Polo L; Rodriguez-Sotelo L; Martinez-Cossiani M; Gonzalez-Valle L; Herrero A; López-de-Sá E; Merino JL;
    Med Clin (Engl Ed); 2021 Sep; 157(6):274-280. PubMed ID: 34568576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic.
    Aldujeli A; Hamadeh A; Tecson KM; Krivickas Z; Maciulevicius L; Stiklioraitis S; Sukys M; Briedis K; Aldujeili M; Briede K; Braukyliene R; Pranculis A; Unikas R; Zaliaduonyte D; McCullough PA
    Am J Cardiol; 2021 May; 147():16-22. PubMed ID: 33631113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic.
    Case BC; Abramowitz J; Shea C; Rappaport H; Yerasi C; Forrestal BJ; Chezar-Azerrad C; Medranda GA; Zhang C; Satler LF; Ben-Dor I; Hashim H; Rogers T; Weintraub WS; Waksman R
    Am J Cardiol; 2021 Oct; 157():42-47. PubMed ID: 34384590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and outcomes in coronavirus disease 2019 (COVID-19) patients with and without hypertension: a retrospective study.
    Yao Q; Ni J; Hu TT; Cai ZL; Zhao JH; Xie QW; Liu C; Wu QQ
    Rev Cardiovasc Med; 2020 Dec; 21(4):615-625. PubMed ID: 33388007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.